Data / Form D filings / Stemina Biomarker Discovery, Inc.
Stemina Biomarker Discovery, Inc.: Form D filings
Stemina Biomarker Discovery, Inc., a biotechnology company in Madison, WI, filed 3 Form D notices with the SEC between 2015 and 2016. The latest, on June 7, 2016, reports $4.3 million sold of a $7.1 million offering to 29 investors.
Find out what Stemina Biomarker Discovery, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 504 S. ROSA ROAD, SUITE 150, Madison, WI, 53719
- Phone
- (608) 204-0104
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1408083
The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 7, 2016 | Amendment | $7,102,187 | $4,251,178 | $2,851,009 | 29 | Dec 31, 2014 | sec.gov |
| Jun 7, 2016 | New notice | $1,100,000 | $1,000,417 | $99,583 | 1 | May 23, 2016 | sec.gov |
| Jan 13, 2015 | New notice | $7,102,187 | $2,602,187 | $4,500,000 | 21 | Dec 31, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew E. Ferrara | Director | |
| R. Andrew Morgan | Director | |
| Scott E. Carr | Director | |
| Kevin E. Krenitsky | Director | |
| Elizabeth L.R. Donley | Executive Officer, Director | |
| Robert E. Burrier | Executive Officer | |
| Marc Andrew Schneebaum | Director |
Every Form D from the week of Jun 6, 2016 · All recent filings in Wisconsin · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Stemina Biomarker Discovery, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.